A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
Clinical trial NCT01371708 · COMPLETED
Trial details
- NCT number
- NCT01371708
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-02
- Primary completion
- 2016-04-22
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.